课题基金 / 基金详情

Nanoscale metallomics and mineralization: advanced spectro-microscopy determination of the role of iron and calcium in Alzheimer's disease

Nanoscale metallomics and mineralization: advanced spectro-microscopy determination of the role of iron and calcium in Alzheimer's disease
纳米级金属组学和矿化:先进的光谱显微镜测定铁和钙在阿尔茨海默病中的作用
批准号:
EP/N033140/1
负责人:
Neil Telling
金额:
$43.01万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

Neil Telling的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The most common form of dementia is Alzheimer's disease, a neurodegenerative disorder that reportedly affects 30 million people worldwide, yet for which there is no cure and only limited opportunities for accurate diagnosis and treatment. The disease is characterised by pathological hallmarks in the brain including dense amyloid protein aggregates (plaques) that are deposited outside cells in the grey matter of the brain, together with significant damage internally in neurons due to 'tangles' of abnormal tau protein. These plaques and tangles are understood to contribute to the death of neurons and the progressive degeneration of the brain. Exactly how this degeneration is mediated by these protein deposits is not yet properly understood. However, oxidative stress damage to neurons, catalysed by highly reactive chemical species known as free radicals, is understood to play a significant role. In addition, substantial evidence now suggests that the dysregulation of iron resulting in a harmful excess of reactive (ferrous) iron in the brain, is a contributing factor in the disease, and may be implicated in the processes leading to oxidative stress. Interactions between aberrant protein deposits and iron, as well as other metals, are common features of neurodegenerative disorders. In Alzheimer's disease, metal-protein interactions are hypothesized to contribute to the formation of deposits containing reactive (harmful) iron observed post-mortem in diseased brain tissue. In addition, unusual calcium bio-mineralisation has been observed within areas of aberrant protein deposition suggesting that calcium could also play a significant role in the disease. Identifying these mineral products is an important first step in describing this aspect of Alzheimer's disease. However in order to make progress in diagnosing and treating the disease, it is necessary to understand how the metal-protein interactions contribute to the disease process at a level facilitating therapeutic intervention, and the extent to which resulting iron and calcium mineralization in the protein deposits can serve as an early-stage marker of the disease. We aim to explore the chemical and mineral state of iron and calcium in Alzheimer's disease brain tissue using sensitive and specific analytical methods, as well performing experiments to investigate how metal-protein interactions can lead to the initiation and evolution (both chemical and structural) of the protein deposits. Further, we will assess how the metal-protein aggregates formed in human brain tissue, as well as those created artificially, respond to treatments with the metal chelating agents that are currently being developed as potential drug therapies for Alzheimer's and other neurodegenerative conditions. To ensure the success of this project we have assembled a unique interdisciplinary research team, with a strong international track record, to build upon our successful preliminary work in this area, applying a combination of advanced synchrotron x-ray microscopy and mass spectrometry techniques to probe nanoscale variations in the bio-inorganic chemistry occurring in Alzheimer's tissue. An important aspect of the project is that in all cases we will support our evaluation using these specialist techniques, with conventional imaging and histology. From this we will build a comprehensive description of this fundamental process in Alzheimer's disease, addressing key outstanding questions about the metal-protein interactions and how they may be modified. The parallels between aberrant protein deposition and altered handling of iron and other metals in related disorders, will allow the approach developed in this project to be readily translated, enabling equivalent impact for other forms of neurodegenerative disease. With clinical advances in chelation therapy and improved scope to track brain iron status non-invasively by clinical MRI, this project is not just timely but also urgent.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1039/c7nr06794a
发表时间: 2018-07-05
期刊: Nanoscale
影响因子: 6.7
作者: [Everett J , Collingwood JF , Tjendana-Tjhin V , Brooks J , Lermyte F , Plascencia-Villa G , Hands-Portman I , Dobson J , Perry G , Telling ND ]
通讯作者: Telling ND
DOI: 10.1039/d0sc04082g
发表时间: 2020-11-12
期刊: Chemical science
影响因子: 8.4
作者: [Anthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C, Lant EC, Lermyte F, Needham RJ, Palau M, Sadler PJ, Shi H, Wang FX, Zhang WY, Zhang Z]
通讯作者: Zhang Z
DOI: 10.1039/d0ra09992a
发表时间: 2021-01-06
期刊: RSC advances
影响因子: 3.9
作者: [Carter OWL, Xu Y, Sadler PJ]
通讯作者: Sadler PJ
Nanoscale Examination of Biological Tissues Using X-ray Spectromicroscopy
使用 X 射线光谱显微镜对生物组织进行纳米级检查
DOI: 10.1017/s143192761801468x
发表时间: 2018
期刊: Microscopy and Microanalysis
影响因子: 2.8
作者: [Everett J]
通讯作者: Everett J
6
    Probing the origin and evolution of low-oxidation state iron and copper nanoparticles in the brain
    • 批准号:
      EP/X031403/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $109.2万
    • 财政年份:
      2024
    • 负责人:
      Neil Telling
    • 依托单位:
    Development of magnetic force biotechnology to facilitate neural regeneration
    • 批准号:
      EP/X014126/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $102.69万
    • 财政年份:
      2023
    • 负责人:
      Neil Telling
    • 依托单位:
    Combined Magneto-Optical and Fluorescence Lifetime Imaging Microscopy: Towards Cellular Level Magnetic Hyperthermia
    • 批准号:
      EP/P011403/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $103.06万
    • 财政年份:
      2017
    • 负责人:
      Neil Telling
    • 依托单位:
    Development and validation of a dynamic drug screening platform for ADME testing
    • 批准号:
      EP/M506862/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $5.86万
    • 财政年份:
      2014
    • 负责人:
      Neil Telling
    • 依托单位:
    海外基金